Clinical Trial

A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated April 10, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
Prospective, randomized, multicenter, multi-arm, subject and vision-assessor-masked, two stage study with Stage 1 as a three-arm initial enrollment period, followed by Stage 2 as a head-to-head study refined based on the Stage 1 data.
Trial Details
NCT Number NCT06922084
Lead Sponsor Berkeley Eye Center
Collaborators: Sengi
Conditions Cataract
Enrollment 320 participants
Start Date 2025-03-17
Primary Completion 2026-04 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2025-04-10